<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Spinal neuroimmune and neuroinflammatory activities have been demonstrated to participate in neuropathic pain. Specifically, pro-inflammatory cytokines, such as IL-1, IL-6, TNF-α, and iNOS have been largely demonstrated to be involved in the onset and development of inflammatory and neuropathic pain (
 <xref rid="ref28" ref-type="bibr" class="xref">He et al., 2014</xref>). In the present study, SNI increased the expression of iNOS at day 7. Treatment with LEO 100 mg/kg significantly decreased the levels of iNOS compared to the SNI-treated group (
 <xref rid="fig3" ref-type="fig" class="xref">Figure 3A</xref>).
</p>
